CANY
MRSN icon

Caxton Associates (New York)’s Mersana Therapeutics MRSN Stock Holding History

Caxton Associates (New York)’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,917
Closed -$221K – 585
2022
Q2 		$221K Buy
+1,917
New +$221K 0.02% 435